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Abstract
Persistent stressors associated with sociodemographic disadvantage exert a physiologic toll,
labeled “allostatis load”, that contributes to disparities in some health conditions. We investigated
the contribution of allostatic load to pain prevalence in US adults. Interviews with 14,184 adults in
the 1999–2004 National Health and Nutrition Examination Survey asked about severe headache,
pain that lasted >24 hours, and widespread pain. Ten biomarkers of allostatic load were quantified
from blood (glycated hemoglobin), serum (C-reactive protein, homocysteine, cholesterol,
triglycerides), urine (creatinine, albumin) and physical measurements (body mass index, systolic
and diastolic blood pressure). Log-binomial regression models estimated prevalence ratios (PR)
and 95% confidence intervals (95%CIs). Prevalence ranged from 3.4% for widespread pain to
26.9% for pain >24 hours. After adjustment for demographic characteristics, low income was
associated with greater prevalence of pain >24 hours (PR=1.65, 95%CI=1.49, 1.83), severe
headache (PR=2.05, 95%CI=1.68, 2.50) and widespread pain (PR=3.67, 95%CI=2.56, 5.27).
Racial/ethnic minorities had lower prevalence of all three pain conditions than non-Hispanic
Whites. While greater allostatic load was associated with elevated prevalence of pain, allostatic
load did not meaningfully attenuate prevalence ratios associated with income or race/ethnicity. We
conclude that greater pain prevalence among low income groups is not explained by greater
allostatic load.
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Introduction
Like many other persistent health conditions, chronic pain occurs in response to a complex
interplay of environmental and genetic influences that alter biological and psychological
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regulatory systems. For example, one conceptual etiologic model of idioapthic pain
conditions depicts two primary pathways of vulnerability: pain amplification and
psychological distress.14 In this study, we investigated an additional hypothesized pathway
of allostatic load.
The concept of allostasis, a complex form of physiological regulation, was developed to
explain pathologic change in regulatory systems that occurs in response to repeated
arousal.54 Unlike homeostasis which limits change by holding constant parameters essential
for life —such as body temperature, pH, and oxygen tension—allostasis evokes change
essential to adaptation.54 Multiple regulatory systems are involved including the
hypothalamic-pituitary-adrenocortical (HPA) axis, sympathetic and parasympathetic
nervous system and immune system. In the short-term, stress mediators from these systems
promote adaptation and the response protects health. However sustained or repeated
deviation from regular physiological parameters produces a biological burden referred, to as
allostatic load,35 that is maladaptive across a range of biological regulatory systems.
Accordingly, studies have used numerous biomarkers to index the degree of allostatic
load.10, 17, 47, 48
Investigations of stressors contributing to allostatic load implicate low socioeconomic status
(SES) and experiences of racial/ethnic-disadvantage. Low SES is associated with greater
exposure to health risk behaviors as well as financial strain, depression, anxiety,
discrimination and boredom. 22, 30, 45, 50 In the United States, non-Hispanic Blacks
experience disproportionately low levels of SES. Many of them also experience effects of
racism, segregation and discrimination that represent additional, long term hazards to
health.3 The pervasive nature of these experiences and repeated efforts to adapt to them are
thought to build allostatic load. For example, groups with low SES have elevated levels of
stress hormones such as cortisol, epinephrine and norepinephrine.9 Many adults in the US
have low income and/or experience racial/ethnic disadvantage. Such groups may be more
susceptible than other groups to highly prevalent conditions, such as chronic pain, because
of the continuous nature of stress that they confront, and the allostatic load that ensues. .
Furthermore, there is good evidence from large, population-based samples that prevalence of
pain disorders is greater in socioeconomically disadvantaged groups. A national study of
neck and lower back pain conducted in Spain, for instance, found inverse monotonic
gradients in prevalence of both conditions across levels of education and income.16
Likewise low household income and unemployment were significantly associated with
chronic, recurrent or long-lasting pain in a representative sample of US adults.27 Similar
socioeconomic associations with pain are reported in the Canadian National Population
Health Survey.42 and in Singapore.58
Cross-sectional evidence shows that high allostatic load is associated with cardiovascular
disease,32, 43 periodontal disease,43 and chronic fatigue syndrome18. In longitudinal studies,
high allostatic load is predictive of all cause mortality3 and declines in cognitive and
physical functioning.46 Whether allostatic load contributes to pain is uncertain, but
nonetheless plausible. For instance, HPA axis activity plays a role in stress-related pain
disorders including chronic headache, chronic pelvic pain, fibromyalgia, chronic fatigue
syndrome and irritable bowel syndrome.11, 13, 21, 56
In this study, we evaluate SES and racial/ethnic group variation in prevalence of commonly-
reported pain symptoms and assess associations between biomarkers of allostatic load and
prevalence of pain in the US adult population. We hypothesized that an index of allostatic
load should account for some or all of the SES and racial/ethnic group gradient in
prevalence of pain symptoms.
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Study design and population
The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional
study designed to provide information on the distribution of various health and nutritional
outcomes as well as potential risk factors. The target population consists of the non-
institutionalized population aged 2 months or older living in the 50 US states, District of
Columbia, and Puerto Rico. NHANES uses a complex, multistage, probability design to
obtain a representative sample of the civilian, non-institutionalized US population. The
primary sampling units (PSUs) are predominantly counties. Segments of these PSUs are
sampled, and from within these segments, a random sample of households is drawn. Each
year NHANES examines about 5,000 persons located in counties across the country. Data
are released in two-year cycles. This paper analyzes data from 1999 – 2004 NHANES
cycles5 in which 14,184 adults 18 years or older completed questions about pain and
provided blood that was used to measure biomarkers of allostatic load.
Classification of three pain conditions
Study participants were classified according to their response to questions about three pain
conditions included in the NHANES Miscellaneous Pain Questionnaire8. Participants were
classified as having severe headache if they responded “yes” to the question, “During the
past 3 months, did you have severe headaches or migraines?” Those responding
affirmatively to the question “During the past month, have you had a problem with pain that
lasted more than 24 hours?” were classified as having experience pain for more than 24
hours (pain >24 hours). Among these subjects, they were classified as having widespread
bodily pain (WBP) if pain was present in the upper right, upper left, lower right, lower left,
and axial regions of the body 20 (p. 805, 1st paragraph). Participants indicated regions of the
body that were affected by pain by pointing to a manikin drawn on a card. Interviewers
encoded responses using 32 pre-coded anatomical descriptions. Respondents reporting fewer
affected sites and those who did not have pain >24 hours were classified as non-cases of
WBP.
Index of allostatic load
The NHANES study measured 10 biomarkers of allostatic load because these are used
widely as an index of allosatic load in epidemiologic studies. 10, 17, 47, 48 The biomarkers
were quantified from blood (glycated hemoglobin), serum (C-reactive protein,
homocysteine, cholesterol, triglycerides), urine (creatinine, albumin) and physical
measurements (body mass index, systolic and diastolic blood pressure). SBP, DBP, and BMI
were obtained from physical examinations6 and the others were obtained from laboratory
examinations.7 Consistent with the method used by Geronimus et al.17 to create an index of
allostatic load, subjects were classified into quartiles for each of the ten biomarkers. An
individual was classified at higher risk for allostatic load if the level of the biomarker was in
the lowest quartile for albumin and urinary creatinine clearance and in the highest quartile
for the other eight biomarkers, namely: serum albumin <4.08 g/dL; BMI ≥ 31.16; serum C-
reactive protein ≥0.45 mg/dL; urinary creatinine clearance < 65.05 mg/dL; diastolic blood
pressure ≥ 78.73 mm Hg; systolic blood pressure ≥ 131.15 mm Hg; serum glycated
hemoglobin ≥5.5%; serum homocysteine ≥9.79 μmol/L; total serum cholesterol ≥ 225.96
mg/dL; serum triglycerides >166.59 mg/dL. The allostatic load index for each individual is
defined as the total number of biomarkers at the highest risk quartile . Individuals with a
missing value for any component of the allostatic load index were excluded from analysis.
Covariates—Analyses considered the following socio-demographic covariates and risk
factors: age, gender, race/ethnicity, income (expressed as the ratio of income to the poverty
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level, i.e. PIR), and smoking status. Smoking was included because of its recognized
relationship with multiple chronic pain conditions 36, 44, 49. Age was defined as a categorical
variable with seven levels: 18-24, 25-34, 35-44, 45-54, 55-64, 65-74, and ≥75 years. Four
categories defined race/ethnicity: Non-Hispanic White (NHW), Non-Hispanic Black (NHB),
Hispanic, and Other. With respect to smoking status, individuals were classified as either
current, former, or never.
SES was operationalized using the ratio of family income to poverty. This widely-cited
derived continuous variable on the NHANES dataset divides family income by the poverty
threshold, taking into account the family size. As such it represents equivalized income
which is more informative about available resources than income alone. A poverty-income
ratio below 1.0 indicates that the family is below the poverty threshold. Hereafter we refer to
poverty-income ratio simply as “income”. For this analysis, income was defined as a
categorical variable with the following levels: low income (< 1.0), medium (from 1.0 up to
but not including the estimated third quartile, 4.79), and high (at or above the estimated third
quartile).
Statistical analysis
Statistical approaches appropriate for complex multi-stage sample surveys were used in all
data analyses, including use of sampling design variables (stratum and primary sampling
units) and sampling weights for examined subjects. Variances of estimated quantities are
computed using Taylor series approximations 231. Prevalence proportions and prevalence
ratios were estimated using log-binomial regression models 51, 19 and their standard errors
were estimated using results established by Natarajan et al 37.
Unadjusted estimates of pain prevalence for each of the three pain outcomes were computed
for groups classified according to the following risk factors and socio-demographic
variables: smoking status, gender, age, race/ethnicity, and PIR. Significance was assessed
using Rao-Scott 41 chi-squares.
Demographically-adjusted prevalence estimates across levels of the allostatic load index
were estimated by fitting a log-binomial regression model treating the allostatic load index
as a categorical variable with six levels (0, 1, 2. 3, 4, ≥5) and adjusting for the following
demographic factors: age, gender, and race/ethnicity. For each of the 10 biomarkers used to
define the allostatic load index, we also fitted a demographically-adjusted log-binomial
regression model treating the biomarker as a categorical variable with three levels: less than
the first quartile, from the first quartile up to but not including the third quartile, and at or
above the third quartile. Significance was assessed using Wald chi-squares.
For each of the three pain conditions, prevalence ratios comparing low and medium to high
PIR were estimated by fitting a series of three log-binomial regression models adjusting for
age, gender, and race/ethnicity with a view towards assessing attenuation in these ratios, if
any. Each successive model included an additional risk factor (smoking status and allostatic
load index as a 6-level categorical variable).. Wald confidence intervals were computed for
prevalence ratios in the log scale and then exponentiated to obtain confidence intervals for
prevalence ratios.
Results
Socio-demographic variation in prevalence of pain
Widespread bodily pain was experienced by an estimated 3.4% of US adults, while more
than one fifth reported severe headache (21.6%) or pain >24 hours (26.9%) (Table 1). For all
three types of reported pain, prevalence was greater for females than for males, and it was
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higher for age groups within the range 25-64 years compared to the oldest- or youngest-age-
groups. In these unadjusted analyses, pain >24 hours occurred more frequently in non-
Hispanic Whites than other race/ethnic groups, whereas severe headache had greatest
prevalence in Hispanics. Prevalence of the three pain conditions was inversely associated
with income, and current smokers had greater prevalence of these pain conditions than either
former-smokers or people who had never smoked.
Associations between allostatic mediators and pain
In analyses that adjusted for age, gender and race/ethnicity, severe headache and pain >24
hours each were associated with most individual biomarkers of allostatic load (Table 2).
Greater prevalence generally was observed in people with markers of high allostatic load.
Specifically, prevalence of both severe headache and pain >24 hours was positively
associated with measures of body mass index, serum C-reactive protein, glycated
hemoglobin and serum triglycerides. Prevalence of both severe headache and pain >24 hours
was negatively associated with serum albumin concentration, signifying higher allostatic
load. However greater prevalence of severe headache was associated with higher values of
urinary creatinine clearance, signifying low allostatic load. Demographically-adjusted
prevalence of WBP generally displayed similar patterns of association with the same
markers of allostatic load, although net differences in prevalence among quartiles of each
marker were small, and only three reached statistical significance (body mass index, serum
C-reactive protein and serum triglycerides). Prevalence of all three pain conditions was
positively associated with higher scores of the allostasis index (Table 2), although the
relationship was not monotonic. However for each pain condition, people who scored at
least 5 on the index had greater prevalence than people with lower scores.
Multivariable analysis of associations between allostatic mediators and pain
Without adjustment for covariates, the mean allostatic load index was inversely associated
with income, and it was greater in non-Hispanic Blacks than in non-Hispanic Whites (results
not tabulated). For example, the low income group had a higher allostatic load (mean index
= 2.64, 95%CI = 2.52, 2.76) than the high income group (mean index = 2.34, 95%CI = 2.25,
2.45). Relative to non-Hispanic Whites (mean index = 2.55, 95%CI = 2.46, 2.63), allostatic
load was greater in non-Hispanic Blacks (mean index=2.75, 95%CI = 2.66, 2.86), although
it was lower in Hispanics (mean index = 2.33, 95%CI = 2.21, 2.46).
Demographically-adjusted pain prevalence ratios for the lowest income category relative to
the highest income category ranged from 1.65 for pain >24 hours to 3.67 for WBP (Table 3,
Model 1). For each pain condition, the middle-income category had a lower prevalence
ratio, and corresponding 95%CIs excluded the null value of 1.0. In contrast, prevalence
ratios for racial/ethnic groups showed no significant variation in prevalence of severe
headache, while for the other two forms of pain, racial/ethnic group minorities each had
lower prevalence relative to the reference group of non-Hispanic Whites.
There were only small changes in prevalence ratios for categories of income after
additionally adjusting for smoking. Associations of income with each pain condition
remained statistically significant, and relative to non-Hispanic Whites, racial/ethnic
minorities continued to have significantly lower prevalence of pain >24 hours and
widespread bodily pain (Table 3, Model 2). Likewise, prevalence ratios were only modestly
attenuated after additional adjustment for the allostatic load index (Model 3). The largest
amount of attenuation was seen for WBP, where the prevalence ratio for the lowest- relative
to the highest-income category was 3.67 (95%CI = 2.56, 5.27) in the demographically-
adjusted model 1 and 2.97 (2.16, 4.10) in the fully-adjusted model 3. Because the 95%CIs in
each model overlapped to a large degree, we interpret this as only modest attenuation of the
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prevalence ratio. Likewise, there was little change in the magnitude of protective prevalence
ratios for racial/ethnic minorities relative to non-Hispanic Whites for pain >24 hours and for
widespread bodily pain. In Model 3, the fully-adjusted association of the allostatic load
index was only modest for severe headache (prevalence ratio = 1.23 (1.02, 1.47) for a score
of ≥5 relative to a score of 0) and for pain >24 hours (prevalence ratio = 1.45 (1.22, 1.73).
However, for widespread pain, prevalence ratios were larger, and statistically significant for
each level of the allostatic load index above the reference level of zero.
Discussion
In this cross-sectional study of US adults, prevalence of all three commonly-occurring pain
symptoms (severe headache, pain ≥ 24 hours, widespread bodily pain) was positively
associated with greater allostatic load. Despite a pattern of greater pain prevalence and
greater allostatic load in lower income groups, allostatic load did not account for the
relationship between income and pain prevalence. Furthermore, although prevalence of pain
>24 hours and of widespread bodily pain was lower in racial/ethnic minorities than in non-
Hispanic Whites, this pattern was not altered after adjusting for allostatic load. While these
findings support the notion that pain is one consequence of the biologic “wear and tear”
induced by low SES, these results do not support the hypothesis that allostatic load accounts
for SES variation in self-reported pain.
Because of its cross-sectional design, this study is unable to compute people's risk of
developing pain, and nor is it possible to establish a temporal sequence between elevation in
biomarkers and onset of pain. Yet the relationship between allostatic load and pain
symptoms is consistent with other evidence that psychological and behavioral stressors
contribute to chronic pain,28 an effect that is mediated primarily through the HPA axis.34
Dysregulation of the HPA axis, a hallmark of allostatic load,33 can be quantified using
measures of corticotrophin-releasing factor, adrenocorticotropin and glucococoricoids.
Indeed, McEwen and Seeman conceived of HPA mediators as “primary” mediators of
allostatic load because they signify the first change in a sequence of events. Specifically,
primary mediators measure cellular events and activity of messenger systems.35 In the same
conceptual model,35 those first changes lead to secondary changes in metabolic processes
and preclinical signs of pathology such as glycosylation of hemoglobin and alterations to
serum lipids. HPA axis mediators were not measured in the NHANES study. Instead, we
used an index comprised of secondary allostatic mediators because previous studies found
them to be elevated in non-Hispanic Blacks and in low income groups,17 a result that we
confirmed using these NHANES 1999-2004 data.
In this study, C-reactive protein was the allostatic load biomarker most strongly associated
with pain symptoms. Although still within “normal” limits, these elevated C-reactive protein
levels signify a general pro-inflammatory state. High-normal serum concentrations of C-
reactive protein are associated with many other diseases that have an inflammatory
component, including cardiovascular disease.29 The association observed here is consistent
with evidence regarding the role of pro-inflammatory cytokines in some types of chronic
pain, most notably fibromyalgia 591 In this study, elevated CRP was associated with greater
prevalence of all three pain conditions. In the multivariable models, the association between
the overall allostatic load index and pain was greatest for widespread bodily pain. The
observed prevalence was based on a stringent case-definition for widespread pain that
yielded overall prevalence of 3.4% which is lower than rates of 5%24 to 11%12 reported
using the Manchester definition. The difference is probably due to the NHANES-criterion
that required widespread pain of more than 24 hours duration in the preceding month.
Greater stringency in case-classification can alter strengths of association with putative risk
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factors. For example, Hunt et al24 found stronger associations between psychosocial factors
and pain using the Manchester definition compared to a less stringent case-definition.
We therefore propose two explanations for the observed associations between this allostatic
load index and pain symptoms. For symptoms of widespread bodily pain, where
inflammation is a likely contributing risk factor, we believe the strong association with the
allostatic load index occurs because one of the index's components is a direct measure of
inflammatory burden (C-reactive protein); the remaining components are secondary
allostatic mediators, thereby providing an additional, indirect marker of HPA axis
dysregulation. In contrast, for headache and pain >24 hours, inflammation probably is less
critical, such that the association with the index of allostatic load occurs only indirectly, to
the extent that secondary indicators of allostatic load signify alterations in the HPA axis.
However, these interpretations are speculative. The NHANES laboratory protocol did not
include direct biomarkers of HPA axis function that have been used in other studies.48
Hence, this study's findings of generally weak associations between these 10 secondary
allostatic mediators and pain do not negate the possibility that primary allostatic mediators
might show strong associations with pain. Indeed, we recommend that future research into
this question focus on primary allostatic mediators.
The observed lack of attenuation of the SES gradient by the allostatic load index suggests
that low SES contributes to pain symptoms primarily through pathways that do not involve
allostatic load. This is in contrast to the notion that the stress of low SES imposes
physiological wear-and-tear that contributes to poor health. While that notion has been
supported by experimental studies of cardiovascular disease and its precursors,5253,
observational epidemiological studies have not necessarily confirmed that allostatic load is
responsible for all or some of the SES gradient in cardiovascular disease and other
disorders.43
The evidence is also ambiguous with respect to the role of allostatic load in explaining
racial/ethnic differences in disease in the United States.3 At first appearance, the lower
prevalence of two pain conditions observed here in racial/ethnic minorities casts further
doubt on the salience of allostatic load as a mediator of racial-group variation in pain. The
finding of similar or lower pain prevalence in racial/ethnic minorities compared to non-
Hispanic whites is consistent with nationally-representative studies that have investigated
migraine55, non-specific headache, neck pain and back pain39 and temporomandibular
disorder and neck pain.26, 39 Yet, racial/ethnic minorities typically report greater sensitivity
to experimental pain,15 and there is evidence that racial/ethnic minorities are disadvantaged
in receiving treatment for pain. 40
Given that allostatic load is elevated in US racial/ethnic minorities relative to non-Hispanic
whites,17 it is implausible that accounting for allostatic load in multivariable modeling might
reverse the observed pattern of lower pain prevalence in minorities. However, before
dismissing the relevance of allostatic load in understanding racial/ethnic variation in pain
prevalence, it should be emphasized that it is the experience and perceptions of disadvantage
that are thought to add to allostatic load, rather than racial/ethnic identity itself. It is
plausible that measures of discrimination or other socially-patterned forms of disadvantage
might be associated with greater prevalence of pain. If that was the case, allostatic load
might constitute a mediator of the relationship. However, this idea cannot be tested using
these data because the NHANES survey did not measure racial/ethnic discrimination.
Smoking rates are negatively related to income in the US4 and in this study smoking was
positively associated with prevalence of pain. We therefore investigated whether smoking
accounted for income disparities in self-reported pain. While prevalence of all three pain
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conditions was highest among people with low income and among current smokers,
statistical adjustment for smoking did not attenuate income-associated prevalence ratio for
severe headache or for pain >24 hours; and there was only modest reduction of the
prevalence ratio for widespread bodily pain. Likewise, adjustment for smoking did not alter
racial/ethnic differences in self-reported pain. Consequently we conclude that while smoking
may be a risk indicator for pain, smoking does not account for differences in variations in
pain prevalence associated with income and with racial/ethnic identity.
An important consideration when interpreting these findings is that the pain symptoms were
reported only during standardized interviews - there were no clinical assessments to
determine specific pain diagnoses. Hence, these reports of headache do not conform with
specific diagnostic categories of headache23, and reported pain in multiple body sites is not
equivalent to fibromyalgia. 57 Nonetheless, global assessments of pain symptoms have
public health relevance by serving as indicators of everyday-pain experiences within the
population. Indeed, simple, interview-based measures for assessing widespread bodily pain
have been advocated as a pragmatic way of investigating population-level distribution and
determinants of chronic pain. 38 A notable benefit of population-based studies, such as
NHANES, is that they do not rely on attendance or referral to specialists, who typically are
needed to render diagnoses of specific chronic pain conditions. Indeed, the US Institute of
Medicine25 noted that national surveillance systems such as NHANES are an essential tool
in monitoring the public health burden created by chronic pain.
In summary, these findings show that greater prevalence of commonly-occurring pain
symptoms is associated with increasing levels of allostatic load, as assessed using secondary
mediators of allostatic load. Yet, greater allostatic load in low SES groups did not account
for their greater prevalence of pain. And conversely, despite greater allostatic load among
racial/ethnic minorities, they had lower prevalence of pain than non-Hispanic Whites. These
findings are consistent with some studies of other chronic diseases by casting doubt on the
salience of secondary mediators of allostatic load in explaining SES variation in commonly-
occurring pain symptoms. While it is possible that primary allostatic mediators, such as
cortisol and catecholamines, might provide an index of allostatic load that is more salient for
these forms of pain, it is possible that other biological, behavioral, or psychological
processes account for SES variation in pain prevalence in the US population.
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In US adults, pain occurs more frequently in lower income groups, although the
relationship is not attributable to their experience of greater allostatic load. While
allostatic load contributes to population variation in pain, other etiologic mechanisms
contributing to pain are needed to account for income-disparities in pain.
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Table 3
Adjusted prevalence ratios for three types of reported pain, NHANES 1999-2004








Poverty:Income ratio (reference group = highest) Low 2.05 (1.68, 2.50) 1.96 (1.60, 2.40) 1.91 (1.57, 2.31)
Mid 1.60 (1.35, 1.89) 1.57 (1.32, 1.86) 1.53 (1.29, 1.82)
Race (reference group =Non-Hispanic White) Non-Hispanic Black 1.00 (0.88, 1.13) 1.01 (0.89, 1.14) 0.99 (0.87, 1.12)
Hispanic 0.99 (0.84, 1.16) 1.01 (0.85, 1.19) 1.00 (0.85, 1.18)
Other 0.93 (0.70, 1.24) 0.95 (0.71, 1.28) 0.95 (0.70, 1.28)
Smoking (reference group = Never smoked) Current 1.17 (1.02, 1.33) 1.16 (1.01, 1.32)
Former 1.04 (0.94, 1.15) 1.03 (0.93, 1.15)
Allostasis index (reference group=0) 1 0.94 (0.77, 1.15)
2 1.04 (0.88, 1.21)
3 1.20 (1.00, 1.43)
4 1.12 (0.92, 1.37)
>=5 1.23 (1.02, 1.47)








Poverty:Income ratio (reference group = highest) Low 1.65 (1.49, 1.83) 1.57 (1.41, 1.75) 1.50 (1.34, 1.68)
Mid 1.31 (1.19, 1.45) 1.27 (1.15, 1.40) 1.24 (1.12, 1.37)
Race (reference group =Non-Hispanic White) Non-Hispanic Black 0.74 (0.65, 0.84) 0.75 (0.66, 0.85) 0.74 (0.65, 0.84)
Hispanic 0.65 (0.55, 0.76) 0.66 (0.56, 0.79) 0.66 (0.56, 0.79)
Other 0.71 (0.50, 0.99) 0.73 (0.52, 1.03) 0.73 (0.51, 1.03)
Smoking (reference group = Never smoked) Current 1.28 (1.15, 1.43) 1.27 (1.14, 1.42)
Former 1.20 (1.11, 1.30) 1.20 (1.11, 1.30)
Allostasis index (reference group=0) 1 1.06 (0.92, 1.23)
2 1.06 (0.88, 1.27)
3 1.25 (1.10, 1.42)
4 1.24 (1.02, 1.50)
>= 5 1.45 (1.22, 1.73)








Poverty:Income ratio (reference group = highest) Low 3.67 (2.56, 5.27) 3.15 (2.27, 4.38) 2.97 (2.16, 4.10)
Mid 1.93 (1.38, 2.72) 1.78 (1.28, 2.47) 1.71 (1.23, 2.39)
Race (reference group =Non-Hispanic White) Non-Hispanic Black 0.50 (0.35, 0.72) 0.52 (0.36, 0.74) 0.50 (0.36, 0.71)
Hispanic 0.61 (0.37, 1.03) 0.66 (0.39, 1.10) 0.66 (0.40, 1.09)
Other 0.26 (0.06, 1.10) 0.28 (0.07, 1.21) 0.27 (0.06, 1.17)
Smoking (reference group = Never smoked) Current 1.78 (1.29, 2.47) 1.75 (1.27, 2.42)
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Former 1.25 (0.84, 1.86) 1.27 (0.85, 1.89)
Allostasis index (reference group=0) 1 2.44 (1.26, 4.70)
2 1.93 (1.01, 3.68)
3 2.49 (1.35, 4.59)
4 2.99 (1.46, 6.12)
>=5 2.83 (1.49, 5.35)
a
Covariates include age(7 groups), gender(2 groups), race/ethn(4), income-poverty-ratio (3).
b
Same covariates as Model 1 plus smoking (3 groups).
c
Same covariates as Model 2 plus allostatic load index (6 groups).
d
Severe Headache: n = 11202; Pain > 24 Hours: n = 11197; Widespread Bodily Pain: n = 11204
J Pain. Author manuscript; available in PMC 2013 July 01.
